Stock Club

Ireland’s budget brings three big changes for investors: capital gains tax falling from 33% to 31%, exit tax on funds dropping from 38% to 35%, and a brand new Irish investment account opening on July 1, 2027. Emmet sits down with Paul Overy, founder of Ask About Wealth and author of The Tricks of the Rich, to work out what it all means for your money.Paul ran the numbers on investing €12,000 a year for eight years at a 7% return. Under deemed disposal, the tax bill came to just over €11,000. Investing directly under CGT, just over €10,000. In the new account, just over €2,000 (before fees, which haven’t been announced yet). They also cover why Paul doesn’t think tax is the real barrier to investing in Ireland, the capital acquisition tax threshold gap, why an 8% rental yield can shrink to under 1%, and the 80/20 rule for turning a high income into lasting wealth.This episode is for educational purposes only and is not financial advice.Chapters00:00 Meet Paul Overy of Ask About Wealth01:23 Ireland’s budget: 3 big changes for investors02:52 Is tax really the barrier to investing?04:13 €12K a year for 8 years: deemed disposal vs CGT vs new account05:38 The fees caveat07:23 Will the banks, Revolut and Trading 212 keep it simple?08:43 Why tax breaks raise all boats10:31 Fear, knowledge and market crashes14:17 Will 31% CGT keep wealthy people in Ireland?15:37 When CGT was halved, receipts tripled17:22 Who will actually use the new account17:45 Is the 1% annual charge a wealth tax?19:37 The real barrier: impartial advice22:39 Who the new account suits best26:12 Capital acquisition tax: the €760K threshold gap28:18 Gifting money while you’re alive30:00 Why Irish people love property32:52 The 8% rental yield that was really 0.7%34:49 Inside Ask About Wealth35:46 Do you know what your pension costs?39:44 Turning income into wealth: the 80/20 rule42:55 The tricks of the rich45:41 Rory McIlroy and doing the workAt MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years.#MyWallSt #StockClub #IrishInvesting #DeemedDisposal #CapitalGainsTax #PersonalFinanceIreland #IrelandBudget

Emmet and Mike step back from individual stock picks this week to dig into something that's been quietly rattling markets: the circular nature of AI industry financing. OpenAI recently walked back its own annualized revenue figure from roughly $68 billion to $50 billion after admitting the larger number included gross revenue that gets immediately redistributed to partners, and the news knocked AI-adjacent stocks across the board.They break down the web of commitments connecting Nvidia, OpenAI, Oracle, Microsoft, and Amazon, where the same dollars seem to flow from investor to AI lab to cloud provider to chipmaker and back again. Citing a Financial Times analysis of the sector, they discuss findings that around 176 deals worth a combined $3.6 trillion exist between roughly 200 entities, with the majority flagged as highly circular. They also cover the scale of hyperscaler debt issuance, OpenAI's delayed IPO timeline, and why market breadth has narrowed so sharply around a handful of AI-exposed names.The episode closes with the regular Following Prophet segment, where Emmet reviews the model portfolio's track record through its third consecutive negative rebalance.Companies & Topics DiscussedOpenAINvidia (NASDAQ:NVDA)Oracle Corporation (NYSE:ORCL)Microsoft Corporation (NASDAQ:MSFT)Amazon.com, Inc. (NASDAQ:AMZN)AnthropicCHAPTERS0:00 Intro: The $10 Bill Analogy for AI's Circular Economy0:59 Welcome & Catching Up3:10 Why This Episode, Why Now4:24 OpenAI's Revenue Walkback: $68B to $50B7:28 OpenAI's IPO Delay & Fundraising Pressure9:44 The FT's "Joining the Dots of Big AI" & the $3.6 Trillion Web11:19 How the Nvidia-OpenAI-Oracle-Microsoft Loop Works14:25 Market Breadth: 40% of the S&P 500 in 10 Names16:02 Hyperscalers Taking on Debt20:47 OpenAI's Gross Margins & Projected Cash Burn23:22 The Amazon Comparison: Building a Moat Through Losses28:11 Will Humanity Keep Pace With AI?32:21 China's Open-Weight Model Approach37:09 Wrapping Up: What We Actually Know37:48 Following Prophet: Three Losing Rebalances in a Row43:18 OutroAt MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years.#MyWallSt #StockClub #AI #AIBubble #OpenAI #Nvidia #StockMarket #Investing #TechStocks

This week Stock Club tries something new: instead of each picking a different stock, Emmet and Mike go head to head on the same one. Mike makes the bear case against Netflix (NASDAQ:NFLX), and Emmet, a 22-year shareholder, argues the bull case, both from today's price after the stock has fallen roughly 50 percent from its all-time high in June 2025.

Mike lays out the risks: stagnant viewership growth, a weak Emmy season without a breakout hit since Stranger Things, saturation in Netflix's most profitable markets, competition for attention from TikTok and YouTube, and the pressure of rising content costs in live sports. Emmet counters with Netflix's position as what he calls the world's default TV channel, improving unit economics, double-digit revenue growth across every region in Q2 2026, a fast-growing ad tier approaching $3 billion in revenue this year, and a valuation that's fallen from roughly 40 times earnings to under 20.

They wrap with their take on the collapsed Warner Bros. Discovery acquisition and why walking away from that deal might have been one of management's smartest moves this year.

#MyWallSt #StockClub #Netflix #NFLX #BullVsBear #StreamingWars #StockAnalysis #ValueInvesting

Stocks Mentioned: Netflix, Inc. (NASDAQ:NFLX)

0:00 Intro: A New Bull vs Bear Format

1:05 Why Talk About Netflix Now?

2:22 The Bear Case Begins: Why Has the Stock Fallen?

3:13 Stagnant Viewership & a Weak Emmy Season

7:37 Saturated Markets: The Growth Problem

9:49 Competing for Attention: TikTok, YouTube & Younger Viewers

18:11 Netflix's Stock Journey: $20 to $130 to $67

19:27 Live Sports Costs & Margin Pressure

21:30 The Streaming Fatigue Problem

28:18 The Bull Case Begins: 22 Years as a Shareholder

33:17 Three 40,000-Foot Observations on Netflix

40:11 The 2026 Selloff as a Buying Opportunity

44:34 Q2 2026 Results: Revenue, Margins & Guidance

46:20 International Growth Across Every Region

49:18 Advertising: The Next Growth Engine

52:36 Why Walking Away From Warner Bros. Discovery Mattered

56:46 Closing Thoughts & Listener Feedback Request

At MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years.

Emmet turns this week's episode into a guessing game, teasing five clues before revealing a 150-year-old company that's become one of the most important businesses in the world: Eli Lilly (NYSE:LLY).

Founded in Indianapolis in 1876, Lilly introduced the world's first commercially available insulin in 1923, pioneered recombinant DNA medicine with Humulin in 1982, and brought the world Prozac in 1986.

Today it's a $1.1 trillion company, and both Bill Mann and Porter Stansberry have separately pitched it as a candidate to become the world's first $10 trillion business.

Emmet breaks down why: Mounjaro and Zepbound drove Q2 2026 revenue up 48 percent to $23 billion, the obesity drug market may address a global population the World Health Organization estimates at 890 million adults, and Lilly's new oral pill Foundayo (orforglipron) just added a convenient alternative to injections. He also covers the experimental triple-agonist drug Retatrutide, Lilly's $5.6 billion Houston manufacturing buildout, and the math behind what a true ten-x over 20 years would actually require.

This months following Prophet, spotlighting this month's standout addition to the model portfolio, Ross Stores.

Stocks Mentioned

Eli Lilly and Company (NYSE:LLY)

Ross Stores, Inc. (NASDAQ:ROST)

At MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years.

#MyWallSt #StockClub #EliLilly #LLY #GLP1 #WeightLossDrugs #TrillionDollarStock #Pharma #StockPicks

Emmet and Mike each pick a stock that's been hammered, down at least 50 percent from its highs, and make the case for why the sell-off has gone too far. Emmet starts with Coupang (NYSE:CPNG), often called the Amazon of South Korea, built around a Rocket Delivery network that gets orders to customers in as little as 15 minutes. Shares have been cut in half since a major customer data breach last November triggered regulatory fines of roughly $410 million, but Emmet digs into the most recent numbers, including payment volume and active user counts, to make the case that the damage to the actual business has been far smaller than the stock price suggests.

Mike then makes the case for Nike (NYSE:NKE), which has fallen even further from its highs and is being removed from the S&P 100 index this month. He walks through where the strategy went wrong, drawing comparisons to brand missteps at Michael Kors and Under Armour, and explains why he still sees a path back for one of the most recognized logos on the planet.

#MyWallSt #StockClub #Coupang #CPNG #Nike #NKE #StockPicks #ValueInvesting #TurnaroundStocks

Stocks Mentioned:

• Coupang, Inc. (NYSE:CPNG) — Emmet's pick
• NIKE, Inc. (NYSE:NKE) — Mike's pick

0:00 Intro: Skipping Next Week & AI Slowdown Talk3:35 Emmet's Pick: Coupang, the "Amazon of South Korea"15:29 The November Data Breach & Its Fallout17:22 Coupang's Q2 2026 Results24:40 Has Coupang Actually Recovered?28:36 Mike's Pick: Nike's Turnaround Story31:06 What Went Wrong: Nike's Strategic Missteps45:20 Nike vs Coupang: Market Cap & Valuation47:54 The $10,000 Split: Coupang or Nike?52:15 Outro

This week Emmet and Mike do the opposite of every other Stock Club episode lately: they go looking for businesses that have nothing to do with artificial intelligence.

Mike makes the case for Waste Management (NYSE:WM), arguing that strict environmental and zoning laws have made it nearly impossible to open a new US landfill since the 1980s, leaving Waste Management and a small handful of incumbents with a nearly uncontested, consolidating market. He also flags Republic Services (NYSE:RSG) and Waste Connections (NYSE:WCN) as additional companies that benefit from the same dynamic.

Emmet pick this week is Viking Holdings (NYSE:VIK), the river and ocean cruise operator built around older, affluent travelers. He walks through Viking's latest quarter, including double digit revenue growth, occupancy north of 90 percent, and advance bookings that already cover most of this year's capacity and a growing share of next year's, along with the leadership handover from founder Torstein Hagen to new CEO Leah Talactac.

These are the kind of businesses that keep compounding quietly while the market obsesses over chips and data centers. Long term investors might want at least one or two names in their portfolios that don't come with an AI story attached.

#MyWallSt #StockClub #WasteManagement #Viking #NonAIStocks #StockPicks #LongTermInvesting #DividendStocks

Stocks Mentioned

Waste Management, Inc. (NYSE:WM)

Viking Holdings Ltd (NYSE:VIK)

Republic Services, Inc. (NYSE:RSG)

Waste Connections, Inc. (NYSE:WCN)

At MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years.

Emmet and Mike recap Investicon 2026, MyWallSt's investor event in Dublin, and unpack two of the biggest ideas to come out of it.

First, they break down a major shift coming for Irish investors around deemed disposal tax and long term investment savings, and why the current eight year exit tax rule has frustrated everyday investors for years.

Then they dig into 24/7 Wall Street's Eric Bleeker's AI infrastructure thesis from the event stage. Bleeker argues that the next phase of the AI boom will be defined by bottlenecks rather than headline chip releases, specifically networking and electricity constraints inside data centers. He unveils Vicor (NASDAQ: VICR), a company building vertical power delivery modules designed to move power conversion physically closer to AI processors, addressing the same kind of proximity problem that made high bandwidth memory and optics into massive markets.

They also break down what a token actually is in plain English and why token usage is becoming the real cost driver behind AI services like Claude and ChatGPT.

#MyWallSt #StockClub #Vicor #VICR #AIStocks #Investicon #ArtificialIntelligence #DataCenters #StockMarket #InvestingIreland

Stocks Mentioned:

• Vicor Corporation (NASDAQ:VICR)

At MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years.

Moderna (NASDAQ:MRNA) is back in the headlines after phase three success for what's being called a cancer vaccine, built on the same mRNA technology that powered its Covid vaccine. We discuss just how significant it is that this treatment has gotten this far in trials, why the pandemic accelerated mRNA research faster than anyone expected, and why the commercial realities of personalized medicine, similar to the challenges facing CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals (NASDAQ:VRTX) with their multi million dollar sickle cell treatment, could complicate scalability even if the science works.

We make the case for why investing in a company trying to cure previously unsolvable diseases is worth serious consideration for stock investors, even beyond the pure economics, and why crossing a scientific milestone like this can open the floodgates for the rest of the biotech industry.

Then we shift to Uber (NYSE:UBER) and the case for why the robotaxi race may not be as simple as Waymo good, Uber bad. Rather than spending billions building its own autonomous vehicle fleet, Uber is positioning itself as the aggregator that Waymo, Zoox, Baidu and a growing list of AV players plug into. We break down CEO Dara Khosrowshahi's argument that the highest utilization operator will have the lowest cost of capital, and count the wave of robotaxi partnerships announced over just the last four months.

We close out on why this is not a simple binary bet, how Uber's ride hailing and delivery business has quietly become far more profitable in recent years, and why autonomous driving commoditization could actually favor Uber's asset light model as the technology scales globally.

Stocks mentioned:

• Moderna Inc (NASDAQ:MRNA)
• CRISPR Therapeutics AG (NASDAQ:CRSP)
• Vertex Pharmaceuticals Inc (NASDAQ:VRTX)
• Uber Technologies Inc (NYSE:UBER)
• Alphabet Inc / Waymo (NASDAQ:GOOGL)
• Tesla Inc (NASDAQ:TSLA)
• Amazon.com Inc / Zoox (NASDAQ:AMZN)
• Lyft Inc (NASDAQ:LYFT)

#StockClub #MyWallst #ModernaStock #UberStock #CancerVaccine #RobotaxiStocks #StocksToBuy

Ahead of Investicon, we run through Motley Fool co-founder David Gardner's ten greatest stock recommendations of all time, a league table that includes Tesla (NASDAQ:TSLA), Netflix (NASDAQ:NFLX), Booking Holdings (NASDAQ:BKNG), Amazon (NASDAQ:AMZN) and Nvidia (NASDAQ:NVDA), his best call by the widest margin. We dig into why he picked each of these growth stocks, what the market looked like at the time, and how a philosophy built for the long term turned early conviction into some of the best investment returns in stock picking history.From backing Nvidia in 2004 on a thesis about graphics demand long before anyone was talking about artificial intelligence, to spotting Booking.com's turnaround story when it was still known as Priceline, we break down the recipe behind these picks and what today's investors can actually learn and apply to finding the best stocks to buy now. We also cover why staying invested through years of drawdowns, rather than selling, was just as important to these results as the original stock picks themselves.Investicon is happening Thursday August 27th in Dublin, featuring David Gardner live alongside Bill Mann, Pieter Slegers of Compounding Quality and Eric Bleeker. Email [email protected] for a shot at one of this week's discount codes, or head to investicon.ie for tickets and details.Stocks mentioned:Tesla Inc (NASDAQ:TSLA)Netflix Inc (NASDAQ:NFLX)Booking Holdings (NASDAQ:BKNG)Amazon.com Inc (NASDAQ:AMZN)Nvidia Corporation (NASDAQ:NVDA)Microsoft Corporation (NASDAQ:MSFT)#StockClub #MyWallst #StocksToBuy #GrowthStocks #InvestingPodcast #NvidiaStock #InvesticonAt MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years.

Stock Club Episode 324

This week on Stock Club, we're joined by Pieter Slegers of Compounding Quality, one of the biggest names to come out of the Substack investing world.

Pieter breaks down why Chapters Group AG (Frankfurt:CHG) has become one of his highest conviction Tiny Titans picks, including the story of driving seven hours to meet the CEO in person and what he learned from comparing the company to Constellation Software (TSX:CSU).

We also dig into Pieter's quality investing framework, his biggest lessons from mistakes of omission like Lotus Bakeries (Euronext:LOTB), and the daily routine that keeps him disciplined as an investor.

Pieter will be joining us on stage at Investicon on Thursday, August 27th at the Market Bar in Dublin, alongside Bill Mann, Eric Bleeker, Simon Zebo, David Gardner, and Robert Johnson. For ticket inquiries, email Brian@MyWallSt. Learn more and get your tickets at https://www.investicon.ie/

#MyWallSt #StockClub #Investicon #CompoundingQuality #QualityInvesting #TinyTitans #StockMarket #Investing

At MyWallSt, we believe great investing is about patience, discipline, and owning outstanding businesses. Our team researches global stocks, publishes transparent performance, and helps investors build long-term wealth without hype or guesswork. Horizon is our long-term buy-and-hold service, while Prophet is a five-minutes-a-month system that has trounced the average market returns over 17 years.